We are live on ! Find out more
LABP

Landos Biopharma, Inc. Common Stock

Delisted

LABP was delisted on the 23rd of May, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
PA
1
Perceptive Advisors
New York
$9.66M
RI
2
RTW Investments
New York
$2.58M -$260K -30,000 -7%
OMC
3
OUP Management Company
Pennsylvania
$804K -$325K -37,509 -23%
BlackRock
4
BlackRock
New York
$193K -$15.5K -1,785 -6%
Renaissance Technologies
5
Renaissance Technologies
New York
$168K -$113K -13,003 -33%
Vanguard Group
6
Vanguard Group
Pennsylvania
$108K +$33.9K +3,905 +31%
BCM
7
Bridgeway Capital Management
Texas
$97K
Macquarie Group
8
Macquarie Group
Australia
$96K
AI
9
ArchPoint Investors
Florida
$83K
SGCA
10
Steel Grove Capital Advisors
Tennessee
$55K +$73.3K +8,450 New
Geode Capital Management
11
Geode Capital Management
Massachusetts
$50K
Deutsche Bank
12
Deutsche Bank
Germany
$27K
State Street
13
State Street
Massachusetts
$16K
Two Sigma Investments
14
Two Sigma Investments
New York
$13K -$23.5K -2,704 -58%
Two Sigma Advisers
15
Two Sigma Advisers
New York
$13K -$12.2K -1,410 -42%
Bank of America
16
Bank of America
North Carolina
$11K -$20.7K -2,380 -59%
Balyasny Asset Management
17
Balyasny Asset Management
Illinois
$10K +$13.6K +1,569 New
Goldman Sachs
18
Goldman Sachs
New York
$9K -$25.8K -2,971 -69%
Man Group
19
Man Group
United Kingdom
$9K +$12.5K +1,439 New
Northern Trust
20
Northern Trust
Illinois
$8K
SWP
21
Stratos Wealth Partners
Ohio
$7K
TRCT
22
Tower Research Capital (TRC)
New York
$7K +$312 +36 +4%
Morgan Stanley
23
Morgan Stanley
New York
$5K -$868 -100 -10%
Fidelity Investments
24
Fidelity Investments
Massachusetts
$1K +$35 +4 +2%
JP Morgan Chase
25
JP Morgan Chase
New York
$1K +$443 +51 +29%